BETA-BLOCKERS, ANGIOTENSIN-CONVERTING ENZYME INHIBITORS OR ANGIOTENSIN RECEPTOR BLOCKERS, AND STATINS REDUCE MORTALITY IN PATIENTS WITH IMPLANTABLE CARDIOVERTER-DEFIBRILLATORS

Hoang M. Lai; Wilbert S. Aronow; Adam Kruger; Harit Desai; Harshad Amin; William H. Frishman; Martin Cohen; Carmine Sorbera

doi:10.1378/chest.134.4_meetingabstracts.p26001

BETA-BLOCKERS, ANGIOTENSIN-CONVERTING ENZYME INHIBITORS OR ANGIOTENSIN RECEPTOR BLOCKERS, AND STATINS REDUCE MORTALITY IN PATIENTS WITH IMPLANTABLE CARDIOVERTER-DEFIBRILLATORS

CHEST Journal ◽

10.1378/chest.134.4_meetingabstracts.p26001 ◽

2008 ◽

Vol 134 (4) ◽

pp. 26P

Author(s):

Hoang M. Lai ◽

Wilbert S. Aronow ◽

Adam Kruger ◽

Harit Desai ◽

Harshad Amin ◽

...

Keyword(s):

Enzyme Inhibitors ◽

Beta Blockers ◽

Angiotensin Receptor Blockers ◽

Angiotensin Converting Enzyme Inhibitors ◽

Implantable Cardioverter Defibrillators ◽

Converting Enzyme ◽

Angiotensin Receptor ◽

Converting Enzyme Inhibitors ◽

Receptor Blockers ◽

Cardioverter Defibrillators

Effect of Beta Blockers, Angiotensin-Converting Enzyme Inhibitors or Angiotensin Receptor Blockers, and Statins on Mortality in Patients With Implantable Cardioverter-Defibrillators

The American Journal of Cardiology ◽

10.1016/j.amjcard.2008.02.103 ◽

2008 ◽

Vol 102 (1) ◽

pp. 77-78 ◽

Cited By ~ 19

Author(s):

Hoang M. Lai ◽

Wilbert S. Aronow ◽

Adam Kruger ◽

Harit Desai ◽

Harshad Amin ◽

...

Keyword(s):

Enzyme Inhibitors ◽

Beta Blockers ◽

Angiotensin Receptor Blockers ◽

Angiotensin Converting Enzyme Inhibitors ◽

Implantable Cardioverter Defibrillators ◽

Converting Enzyme ◽

Angiotensin Receptor ◽

Converting Enzyme Inhibitors ◽

Receptor Blockers ◽

Cardioverter Defibrillators

Use of beta-blockers, angiotensin-converting enzyme inhibitors, and angiotensin receptor blockers to prevent atrial fibrillation

Current Cardiology Reports ◽

10.1007/s11886-006-0075-1 ◽

2006 ◽

Vol 8 (5) ◽

pp. 356-364 ◽

Cited By ~ 4

Author(s):

Kristian Wachtell ◽

Richard B. Devereux ◽

Paulette A. Lyle

Keyword(s):

Atrial Fibrillation ◽

Angiotensin Converting Enzyme ◽

Enzyme Inhibitors ◽

Beta Blockers ◽

Angiotensin Receptor Blockers ◽

Angiotensin Converting Enzyme Inhibitors ◽

Converting Enzyme ◽

Angiotensin Receptor ◽

Converting Enzyme Inhibitors ◽

Receptor Blockers

Beta-blockers, calcium channel blockers, angiotensin converting enzyme inhibitors and angiotensin receptor blockers: should they be stopped or not before ambulatory anaesthesia?

Current Opinion in Anaesthesiology ◽

10.1097/aco.0b013e32833eeb19 ◽

2010 ◽

Vol 23 (6) ◽

pp. 687-690 ◽

Cited By ~ 26

Author(s):

Ian Smith ◽

Ian Jackson

Keyword(s):

Angiotensin Converting Enzyme ◽

Enzyme Inhibitors ◽

Beta Blockers ◽

Angiotensin Receptor Blockers ◽

Angiotensin Converting Enzyme Inhibitors ◽

Channel Blockers ◽

Converting Enzyme ◽

Angiotensin Receptor ◽

Converting Enzyme Inhibitors ◽

Receptor Blockers

Prevalence of Use of Antiplatelet Drugs, Beta Blockers, Statins, and Angiotensin-Converting Enzyme Inhibitors or Angiotensin Receptor Blockers in Older Patients With Coronary Artery Disease in an Academic Nursing Home

Journal of the American Medical Directors Association ◽

10.1016/j.jamda.2007.10.010 ◽

2008 ◽

Vol 9 (2) ◽

pp. 124-127 ◽

Cited By ~ 14

Author(s):

Julie Joseph ◽

Madhavi Koka ◽

Wilbert S. Aronow

Keyword(s):

Older Patients ◽

Enzyme Inhibitors ◽

Beta Blockers ◽

Angiotensin Receptor Blockers ◽

Angiotensin Converting Enzyme Inhibitors ◽

Converting Enzyme ◽

Angiotensin Receptor ◽

Converting Enzyme Inhibitors ◽

Receptor Blockers ◽

Artery Disease

Effects of antihypertensive agents, alpha receptor blockers, beta blockers, angiotensin-converting enzyme inhibitors, angiotensin receptor blockers and calcium channel blockers, on oxidative stress

Journal of Hypertension ◽

10.1097/00004872-200306000-00022 ◽

2003 ◽

Vol 21 (6) ◽

pp. 1207-1211 ◽

Cited By ~ 32

Author(s):

Yavuz Baykal ◽

M Ilker Yilmaz ◽

Turgay Celik ◽

Faysal Gok ◽

Hamiyet Rehber ◽

...

Keyword(s):

Enzyme Inhibitors ◽

Beta Blockers ◽

Angiotensin Receptor Blockers ◽

Antihypertensive Agents ◽

Angiotensin Converting Enzyme Inhibitors ◽

Channel Blockers ◽

Converting Enzyme ◽

Angiotensin Receptor ◽

Converting Enzyme Inhibitors ◽

Receptor Blockers

Faculty Opinions recommendation of Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers in Myocardial Infarction Patients With Renal Dysfunction.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.726264595.793522878 ◽

2016 ◽

Author(s):

Wilbert Aronow

Keyword(s):

Myocardial Infarction ◽

Angiotensin Converting Enzyme ◽

Renal Dysfunction ◽

Enzyme Inhibitors ◽

Angiotensin Receptor Blockers ◽

Angiotensin Converting Enzyme Inhibitors ◽

Converting Enzyme ◽

Angiotensin Receptor ◽

Converting Enzyme Inhibitors ◽

Receptor Blockers

Melanoma incidence and exposure to angiotensin-converting enzyme inhibitors and angiotensin receptor blockers

Cancer Epidemiology ◽

10.1016/j.canep.2009.10.005 ◽

2009 ◽

Vol 33 (5) ◽

pp. 391-395 ◽

Cited By ~ 14

Author(s):

E.R. Koomen ◽

R.M.C. Herings ◽

H.J. Guchelaar ◽

T. Nijsten

Keyword(s):

Angiotensin Converting Enzyme ◽

Enzyme Inhibitors ◽

Angiotensin Receptor Blockers ◽

Angiotensin Converting Enzyme Inhibitors ◽

Converting Enzyme ◽

Angiotensin Receptor ◽

Converting Enzyme Inhibitors ◽

Melanoma Incidence ◽

Receptor Blockers

Influence of angiotensin converting enzyme inhibitors/angiotensin receptor blockers on the risk of all‐cause mortality and other clinical outcomes in patients with confirmed COVID‐19: A systemic review and meta‐analysis

Journal of Clinical Hypertension ◽

10.1111/jch.14329 ◽

2021 ◽

Author(s):

Na Jia ◽

Guifang Zhang ◽

Xuelin Sun ◽

Yan Wang ◽

Sai Zhao ◽

...

Keyword(s):

Enzyme Inhibitors ◽

Angiotensin Receptor Blockers ◽

Meta Analysis ◽

Angiotensin Converting Enzyme Inhibitors ◽

Systemic Review ◽

Converting Enzyme ◽

Angiotensin Receptor ◽

Converting Enzyme Inhibitors ◽

All Cause Mortality ◽

Receptor Blockers

Comparative Effectiveness of Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers for Hypertension on Clinical End Points: A Cohort Study

Journal of Clinical Hypertension ◽

10.1111/j.1751-7176.2012.00687.x ◽

2012 ◽

Vol 14 (10) ◽

pp. 731-731 ◽

Cited By ~ 1

Author(s):

John J.V. McMurray ◽

Robert M. Califf ◽

Angelyn M. Bethel ◽

Steven M. Haffner ◽

Rury R. Holman

Keyword(s):

Cohort Study ◽

Angiotensin Converting Enzyme ◽

Comparative Effectiveness ◽

Enzyme Inhibitors ◽

Angiotensin Receptor Blockers ◽

Angiotensin Converting Enzyme Inhibitors ◽

Converting Enzyme ◽

Angiotensin Receptor ◽

Converting Enzyme Inhibitors ◽

Receptor Blockers

ANGIOTENSIN RECEPTOR BLOCKERS AND ANGIOTENSIN CONVERTING ENZYME INHIBITORS IN COVID-19 –META-ANALYSIS/META-REGRESSION ADJUSTED FOR CONFOUNDING FACTORS

CJC Open ◽

10.1016/j.cjco.2021.03.001 ◽

2021 ◽

Author(s):

TERRY LEE ◽

A CAU ◽

MP CHENG ◽

A LEVIN ◽

TC LEE ◽

...

Keyword(s):

Enzyme Inhibitors ◽

Angiotensin Receptor Blockers ◽

Meta Analysis ◽

Angiotensin Converting Enzyme Inhibitors ◽

Confounding Factors ◽

Converting Enzyme ◽

Angiotensin Receptor ◽

Converting Enzyme Inhibitors ◽

Receptor Blockers ◽

Meta Regression